Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infections and anti-tumor necrosis factor alpha therapy.

× No keyword cloud information.

66 in total

Review 1. Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors: K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal: Ann Rheum Dis Date: 2004-07-08 Impact factor: 19.103

2. Cellulitis caused by Capnocytophaga cynodegmi associated with etanercept treatment in a patient with rheumatoid arthritis.

Authors: J C Gerster; J Dudler
Journal: Clin Rheumatol Date: 2004-12 Impact factor: 2.980

Review 3. [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors: D Meyer-Olson; K Hoeper; R E Schmidt
Journal: Z Rheumatol Date: 2010-12 Impact factor: 1.372

4. Is There a Potential Role for Anti-tumor Necrosis Factor Therapy in Patients with Human Immunodeficiency Virus?

Authors: Jason J Emer
Journal: J Clin Aesthet Dermatol Date: 2009-04

5. Long term safety of etanercept in elderly subjects with rheumatic diseases.

Authors: R Fleischmann; S W Baumgartner; M H Weisman; T Liu; B White; P Peloso
Journal: Ann Rheum Dis Date: 2005-09-08 Impact factor: 19.103

Review 6. Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.

Authors: Nirmal Kaur; Thomas C Mahl
Journal: Dig Dis Sci Date: 2004-09 Impact factor: 3.199

Review 7. Update on tuberculosis and other opportunistic infections associated with drugs blocking tumour necrosis factor {alpha}.

Authors: K L Winthrop
Journal: Ann Rheum Dis Date: 2005-11 Impact factor: 19.103

8. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.

Authors: F Tubach; D Salmon; P Ravaud; Y Allanore; P Goupille; M Bréban; B Pallot-Prades; S Pouplin; A Sacchi; R M Chichemanian; S Bretagne; D Emilie; M Lemann; O Lortholary; O Lorthololary; X Mariette
Journal: Arthritis Rheum Date: 2009-07

9. Late infection of total knee arthroplasty inflamed by anti-TNFalpha, Infliximab therapy in rheumatoid arthritis.

Authors: Takashi Yurube; Koichiro Takahi; Hajime Owaki; Takeshi Fuji; Masahiro Kurosaka; Minoru Doita
Journal: Rheumatol Int Date: 2009-05-16 Impact factor: 2.631

10. TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells.

Authors: Haishan Li; Kun Luo; C David Pauza
Journal: J Immunol Date: 2008-11-15 Impact factor: 5.422